Vaginal Repair for prolapse, TVT procedure
Procedure- TVT at the time of Vaginal Repair
- TVT 3 months after Vaginal Repair
Other names: Incontinence surgery, Mid-urethra sling, Prolapse surgery., Prolapse repair
NCT Number: NCT00308009
It is unknown whether it is best to do the TVT( procedure for urinary stress incontinence in women) at the time of prolapse surgery or at a later date. Women with both conditions were randomized to both procedures together or the TVT 3 months after the prolapse surgery. Any or no leakage when couching was the main end-point, evaluated 1 year after the last surgery
Looking for future studies?
Notify MeFemale
Interventional
Not applicable
All women were evaluated by the POP-Q (pelvic Organ Prolapse Quantification) prior to surgery and 1 year after.
Examination for urinary leakage was done prior to surgery and 1 year after. Group 2 was also examined after prolapse surgery to see if TVT was still needed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Pelvic Organ Prolapse that needs surgical repair and objectively proven urinary stress incontinence -
Exclusion criteria
Not agreed to participate in randomization
-
Other names: Incontinence surgery, Mid-urethra sling, Prolapse surgery., Prolapse repair
Time frame: 1 year
Time frame: 1 year
Time frame: 1 year
Ullevaal University Hospital
Other
Multicenter Prospective Randomized Trial Comparing to Strategies When Incontinence Surgery is Needed in Addition to Prolapse Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03052985
Digestive System Diseases, Female Urogenital Diseases
Aix-en-Provence, France
View Trial DetailsNCT05312047
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Badalona, Barcelona, Spain
View Trial DetailsNCT03841513
Bowel Dysfunction, Digestive System Diseases
Chicago, Illinois, United States
View Trial DetailsNCT05440539
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Houston, Texas, United States
View Trial Details